<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://www.gourt.com/Health/Pharmacy/Drugs-and-Medications/I/Imiquimod.html">
<title>Imiquimod RSS : Gourt</title>
<link>http://www.gourt.com/Health/Pharmacy/Drugs-and-Medications/I/Imiquimod.html</link>
<description></description>
<dc:language>en-us</dc:language>
<dc:rights>Copyright 2007, Gourt.com</dc:rights>
<dc:date>2009-11-05T11:58+12:00
</dc:date>
<dc:publisher>rtruog@gourt.com</dc:publisher>
<dc:creator>rtruog@gourt.com</dc:creator>
<dc:subject>Imiquimod RSS : Gourt</dc:subject>
<syn:updatePeriod>hourly</syn:updatePeriod>
<syn:updateFrequency>1</syn:updateFrequency>
<syn:updateBase>1901-01-01T00:00+00:00</syn:updateBase>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://twitter.com/trialscentral/statuses/5428468465" />
  <rdf:li rdf:resource="http://twitter.com/trialscentral/statuses/5428442561" />
  <rdf:li rdf:resource="http://twitter.com/medicineh/statuses/5382861934" />
  <rdf:li rdf:resource="http://twitter.com/therapeuticsh/statuses/5382859263" />
  <rdf:li rdf:resource="http://twitter.com/la_press/statuses/5382730173" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://twitter.com/trialscentral/statuses/5428468465">
<title>Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases   http://bit.ly/jCqla</title>
<link>http://twitter.com/trialscentral/statuses/5428468465</link>
<description><![CDATA[Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases   http://bit.ly/jCqla]]></description>
</item>

<item rdf:about="http://twitter.com/trialscentral/statuses/5428442561">
<title>Topical Imiquimod and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating With Advanced Breast Cancerhttp://bit.ly/z5kz6</title>
<link>http://twitter.com/trialscentral/statuses/5428442561</link>
<description><![CDATA[Topical Imiquimod and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating With Advanced Breast Cancerhttp://bit.ly/z5kz6]]></description>
</item>

<item rdf:about="http://twitter.com/medicineh/statuses/5382861934">
<title>New article: A Review of Topical Imiquimod in the Management of Basal Cell Carcinoma, Actinic Kerat.. http://bit.ly/3RCQDD</title>
<link>http://twitter.com/medicineh/statuses/5382861934</link>
<description><![CDATA[New article: A Review of Topical Imiquimod in the Management of Basal Cell Carcinoma, Actinic Kerat.. http://bit.ly/3RCQDD]]></description>
</item>

<item rdf:about="http://twitter.com/therapeuticsh/statuses/5382859263">
<title>New article: A Review of Topical Imiquimod in the Management of Basal Cell Carcinoma, Actinic Kerat.. http://bit.ly/3RCQDD</title>
<link>http://twitter.com/therapeuticsh/statuses/5382859263</link>
<description><![CDATA[New article: A Review of Topical Imiquimod in the Management of Basal Cell Carcinoma, Actinic Kerat.. http://bit.ly/3RCQDD]]></description>
</item>

<item rdf:about="http://twitter.com/la_press/statuses/5382730173">
<title>New article: A Review of Topical Imiquimod in the Management of Basal Cell Carcinoma, Actinic Kerat.. http://bit.ly/3RCQDD</title>
<link>http://twitter.com/la_press/statuses/5382730173</link>
<description><![CDATA[New article: A Review of Topical Imiquimod in the Management of Basal Cell Carcinoma, Actinic Kerat.. http://bit.ly/3RCQDD]]></description>
</item>

</rdf:RDF>